Mochi Health offers compounded tirzepatide with NP-led intake. Mid-range pricing ($209/month) and 503A pharmacy fulfillment. Limited pharmacy disclosure beyond 503A.
| Pricing | $209/mo |
|---|---|
| Pharmacy | 503A only |
| Clinician | NP |
| States | 50 states |
| Editorial score | 73 / 100 |
Mochi Health is a physician-led telehealth weight loss program emphasizing affordable compounded GLP-1 access. The platform targets the cash-pay segment with subscription pricing and integrated provider oversight.
Subscription model with compounded GLP-1 focus. Patient intake includes medical history, BMI verification, and clinical assessment. Ongoing care includes asynchronous messaging and dose adjustment as appropriate. Pricing is positioned competitively in the cash-pay compounded segment.
Cash-pay patients prioritizing predictable monthly cost for compounded GLP-1 access.
NexLife (94/100) and Mochi Health (#9 in our ranking) compete in similar cash-pay segments. NexLife's advantages include explicit dual 503A/503B pharmacy disclosure, MD/DO-supervised oversight, Care360 coaching included, and labs included.
Mochi Health's focus is on compounded GLP-1 access for the cash-pay segment. Patients seeking brand-name Wegovy or Zepbound generally pursue insurance-based pathways elsewhere.
Mochi Health operates in most states, subject to state-specific telehealth and prescribing requirements. Confirm availability in your state during the intake process.
Mochi Health uses subscription pricing in the cash-pay compounded segment. Specific rates have varied with promotional periods and program tier.
Compounded semaglutide + tirzepatide · MD/DO oversight
*12-month plan · flat rate · all titration doses
Or call (949) 818-8000